Skip to main content

Research Repository

Advanced Search

All Outputs (6)

Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults (2016)
Journal Article
Wiffen, P. J., Knaggs, R., Derry, S., Cole, P., Phillips, T., & Moore, R. A. (2016). Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults. Cochrane Database of Systematic Reviews, Article CD012227. https://doi.org/10.1002/14651858.CD012227.pub2

BACKGROUND Paracetamol, either alone or in combination with codeine or dihydrocodeine, is commonly used to treat chronic neuropathic pain. This review sought evidence for efficacy and harm from randomised double-blind studies. OBJECTIVES To... Read More about Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults.

Hydromorphone for cancer pain (2016)
Journal Article
Bao, Y. J., Hou, W., Kong, X. Y., Yang, L., Xia, J., Hua, B. J., & Knaggs, R. (2016). Hydromorphone for cancer pain. Cochrane Database of Systematic Reviews, Article CD011108. https://doi.org/10.1002/14651858.CD011108.pub2

BACKGROUND Cancer pain is an important and distressing symptom that tends to increase in frequency and intensity as the cancer advances. For people with advanced cancer, the prevalence of pain can be as high as 90%. It has been estimated that 30%... Read More about Hydromorphone for cancer pain.

Fentanyl for neuropathic pain in adults (2016)
Journal Article
Derry, S., Stannard, C., Cole, P., Wiffen, P. J., Knaggs, R., Aldington, D., & Moore, R. A. (2016). Fentanyl for neuropathic pain in adults. Cochrane Database of Systematic Reviews, Article CD011605. https://doi.org/10.1002/14651858.CD011605.pub2

BACKGROUND Opioid drugs, including fentanyl, are commonly used to treat neuropathic pain, and are considered effective by some professionals. Most reviews have examined all opioids together. This review sought evidence specifically for fentanyl, a... Read More about Fentanyl for neuropathic pain in adults.

Is tapentadol different from classical opioids?: a review of the evidence (2016)
Journal Article
Langford, R. M., Knaggs, R., Farquhar-Smith, P., & Dickenson, A. H. (2016). Is tapentadol different from classical opioids?: a review of the evidence. British Journal of Pain, 10(4), https://doi.org/10.1177/2049463716657363

Tapentadol is a single molecule able to deliver analgesia by two distinct mechanisms, a feature which differentiates it from many other analgesics. Pre-clinical data demonstrate two mechanisms of action: mu-opioid receptor agonist activity and noradr... Read More about Is tapentadol different from classical opioids?: a review of the evidence.

Hydromorphone for neuropathic pain in adults (2016)
Journal Article
Stannard, C., Gaskell, H., Derry, S., Aldington, D., Cole, P., Cooper, T. E., …Moore, R. A. (2016). Hydromorphone for neuropathic pain in adults. Cochrane Database of Systematic Reviews, Article CD011604. https://doi.org/10.1002/14651858.CD011604.pub2

BACKGROUND Opioid drugs, including hydromorphone, are commonly used to treat neuropathic pain, and are considered effective by some professionals. Most reviews have examined all opioids together. This review sought evidence specifically for hydrom... Read More about Hydromorphone for neuropathic pain in adults.

Describing the characteristics, treatment pathways, outcomes, and costs of people with persistent noncancer pain managed by community pain clinics and generating an indicative estimate of cost-effectiveness: feasibility study protocol (2016)
Journal Article
AlAujan, S., AlMazrou, S., Knaggs, R. D., & Elliott, R. A. (2016). Describing the characteristics, treatment pathways, outcomes, and costs of people with persistent noncancer pain managed by community pain clinics and generating an indicative estimate of cost-effectiveness: feasibility study protocol. Journal of Multidisciplinary Healthcare, 9, https://doi.org/10.2147/JMDH.S97904

BACKGROUND Low back pain (LBP) and fibromyalgia (FM), also known as chronic widespread pain (CWP), are highly prevalent chronic painful conditions that have substantial impact on patients, health care systems, and society. Diagnosis is complex and... Read More about Describing the characteristics, treatment pathways, outcomes, and costs of people with persistent noncancer pain managed by community pain clinics and generating an indicative estimate of cost-effectiveness: feasibility study protocol.